BRIEF-Johnson & Johnson Temporarily Pauses All Dosing In Our Janssen Covid-19 Vaccine Candidate Clinical Trials

Johnson & Johnson: * JOHNSON & JOHNSON TEMPORARILY PAUSES ALL DOSING IN OUR JANSSEN COVID-19 VACCINE CANDIDATE CLINICAL TRIALS

* J&J - TEMPORARILY PAUSED FURTHER DOSING IN ALL OUR COVID-19 VACCINE CANDIDATE CLINICAL TRIALS DUE TO UNEXPLAINED ILLNESS IN STUDY PARTICIPANT * J&J - PARTICIPANT'S ILLNESS BEING REVIEWED, EVALUATED BY ENSEMBLE INDEPENDENT DATA SAFETY MONITORING BOARD,INTERNAL CLINICAL AND SAFETY PHYSICIANS

* J&J- ADVERSE EVENTS – ILLNESSES, ACCIDENTS, ETC. - EVEN THOSE THAT ARE SERIOUS, ARE AN EXPECTED PART OF ANY CLINICAL STUDY, ESPECIALLY LARGE STUDIES Source text: https://bit.ly/2GIufLt Further company coverage:

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)